Handa Pharmaceuticals (6620.TWO) Earnings Analysis
Handa Pharmaceuticals (6620.TWO) next reports earnings on 2026-08-19, consensus EPS 0.285 TWD. Last quarter (2026-05-07) it beat with EPS 0.4577 TWD vs 0.43 TWD est (+6.4%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 20.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6620.TWO next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | 0.285 TWD |
| Revenue estimate | 0.21B |
6620.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.4577 TWD | 0.43 TWD | +6.4% | Beat |
| 2026-03-12 | 1.12 TWD | 0.43 TWD | +160.5% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
6620.TWO valuation and analyst view
| Trailing P/E | 20.68 |
|---|---|
| Trailing EPS | 3.876 TWD |
| Price / book | 2.66 |
| Dividend yield | 2.45% |
| Market cap | 14.47B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Handa Pharmaceuticals (6620.TWO)'s next earnings date?
Handa Pharmaceuticals is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 0.285 TWD and revenue estimate of 0.21B.
Did 6620.TWO beat earnings last quarter?
In its 2026-05-07 report, 6620.TWO posted EPS of 0.4577 TWD versus a 0.43 TWD estimate — a beat of 6.4%.
What is 6620.TWO's earnings track record?
Over the last 2 reported quarters with consensus data, 6620.TWO beat estimates 2 times (100%).
What is 6620.TWO's current P/E ratio and EPS?
6620.TWO trades at a trailing P/E of 20.68 on trailing EPS of 3.875933089136036 TWD.
What do analysts rate 6620.TWO?
6620.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.